Biotech News News 24 November 2025

IonQ Stock Jumps After Quantum Breakthroughs and Biotech Deal: IONQ Price, Forecast and Outlook as of December 5, 2025

IonQ, Inc. (NYSE: IONQ) is once again at the center of the quantum-computing spotlight. After a sharp pullback in November, the quantum hardware specialist has ripped higher into early December on the back of record-breaking technical milestones, a new biotech

5 December 2025

Praxis Precision Medicines (PRAX) Stock Surges on FDA Progress and Epilepsy Trial Wins: Latest News and 2026 Forecast

Updated December 5, 2025 – all developments since December 4, 2025 Praxis Precision Medicines, Inc. (NASDAQ: PRAX) has moved back into the market spotlight after a flurry of major announcements on December 4, 2025. The biotech’s stock — already one

5 December 2025

Biotech News · Epilepsy Research · FDA Updates · Investment Forecasts · NASDAQ:PRAX · Stock Market

Polyrizon (PLRZ) Stock Doubles on Naloxone Hydrogel Breakthrough and PL‑14 Manufacturing Milestone – What Investors Need to Know on December 4, 2025

Polyrizon Ltd. (NASDAQ: PLRZ) has exploded into the spotlight after a two‑day run that has turned an obscure micro‑cap biotech into one of the most talked‑about healthcare stocks on the Nasdaq. By early afternoon on December 4, 2025, Polyrizon shares

4 December 2025

Biotech News · Financial Updates · Investment Insights · NASDAQ:PLRZ · Pharmaceutical Industry · Stock Market

Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

On December 2, 2025, Bristol-Myers Squibb (NYSE: BMY) found itself at the center of two very different storylines: a revived $6.7 billion Celgene lawsuit and strong hematology data at ASH 2025. Together with a hefty dividend and low valuation multiples,

3 December 2025

Biotech News · Investment Analysis · Lawsuits · NYSE:BMY · Pharmaceuticals · Stock Market

Amgen Stock (AMGN) Today: Q3 2025 Earnings Beat, MariTide Obesity Drug Outlook and 2030 Price Forecast

Updated December 1, 2025 Amgen stock at a glance on December 1, 2025 Amgen Inc. (NASDAQ: AMGN) closed today at $337.49, down about 2.3% on the session, according to real‑time quote data. StockAnalysis Despite today’s pullback, the stock has had

1 December 2025

Biotech News · Earnings Reports · Investment Strategies · Market Forecasts · NASDAQ:AMGN · Stock Analysis

Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

On December 1, 2025, Q32 Bio Inc. (NASDAQ: QTTB) suddenly became one of the most-watched small-cap biotech stocks on Wall Street. Shares of Q32 Bio surged intraday by roughly 90%–170% at various points in Monday’s session, with trading volume soaring

1 December 2025

Biotech News · Financial Outlook · Investment Analysis · Mergers & Acquisitions · NASDAQ:AKBA · NASDAQ:QTTB · Stock Market

AbbVie (ABBV) Stock Today: Price, Analyst Views, Medicare News and New Biotech Award – November 25, 2025

AbbVie Inc. (NYSE: ABBV) ended Tuesday, November 25, 2025, on a firmer footing, closing at $231.80, up about 1.0% on the day and recovering some of Monday’s pullback. The move came amid a flurry of fresh headlines: U.S. Medicare confirmed

25 November 2025

Analyst Opinions · Biotech News · Investment Insights · Medicare Updates · NYSE:ABBV · Stock Market

ALT Stock Today (November 25, 2025): Altimmune Extends Rally as Pemvidutide Nears Critical FDA Moment

Key Takeaways ALT stock price today: how Altimmune is trading on November 25, 2025 Altimmune Inc. (NASDAQ: ALT) continues its November rebound. As of early trading on Tuesday, November 25, ALT is changing hands around $5.1 per share, roughly flat

25 November 2025

Biotech News · FDA Updates · Investing · NASDAQ:ALT · Pharmaceutical Industry · Stock Market

TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had a busy news day on Monday — and the stock still finished sharply lower. Shares of the small-cap biotech closed around $14.29 on November 25, 2025, down roughly 11% on the session, putting

25 November 2025

Biotech News · Company Updates · Financial Analysis · Investing · NASDAQ:TNXP · Stock Market

CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy

Monday, November 24, 2025 Clearside Biomedical’s CLSD stock is in freefall today after the eye‑disease biotech announced a voluntary Chapter 11 bankruptcy filing and plans to pursue a court‑supervised sale of its business and assets. By late afternoon on Monday,

24 November 2025

Bankruptcy · Biotech News · Financial News · Investment Analysis · NASDAQ:CLSD · Stock Market

OSR Holdings (OSRH) Jumps Over 15% Today on Vaximm Deal Momentum: Stock Price, Nasdaq Risk and What Comes Next

OSR Holdings, Inc. (NASDAQ: OSRH) is back on traders’ screens today, November 24, 2025, with the micro-cap healthcare stock extending last week’s rally sparked by its cancer-immunotherapy subsidiary Vaximm AG. As of early afternoon U.S. trading on Monday, OSRH is

24 November 2025

Biotech News · Financial Analysis · Investing · Nasdaq · NASDAQ:OSRH · Stock Market

Novavax Stock (NVAX) on November 24, 2025: Price, Sanofi Deal, Shah Capital Pressure and What It All Means for Investors

All figures current as of the U.S. market close on Friday, November 21, 2025. NVAX will next trade when markets reopen on Monday, November 24, 2025. Quick snapshot for NVAX heading into November 24, 2025 Novavax stock price today: where

24 November 2025

Biotech News · Financial Analysis · Investing · Novavax · Stock Market

Biotech News News 24 November 2025 - 5 December 2025